Related Experiment Video
Updated: Aug 10, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Regulation of nuclear factor-kappaB in intestinal epithelial cells in a cell model of inflammation
Fadia R Homaidan1, Iman Chakroun, Marwan E El-Sabban
1Department of Physiology, American University of Beirut, Faculty of Medicine, Beirut, Lebanon. fh01@aub.edu.lb
Insights
Interleukin-1 (IL-1) activates nuclear factor-kappaB (NF-kappaB) in intestinal cells, influencing inflammation and cell survival. This suggests NF-kappaB is a potential therapeutic target for inflammatory bowel disease.
Area of Science:
- Cellular and Molecular Biology
- Immunology
- Gastroenterology
Background:
- Interleukin-1 (IL-1) is an inflammatory cytokine found at elevated levels in inflamed mucosa.
- IL-1 contributes to its effects on intestinal epithelial cells (IEC) by inducing ceramide production.
Purpose of the Study:
- To investigate the role of nuclear factor-kappaB (NF-kappaB) in IL-1-treated IEC.
- NF-kappaB is recognized as a pro-inflammatory and anti-apoptotic factor.
Main Methods:
- Assessed NF-kappaB activity using electrophoretic mobility shift assay.
- Quantified levels of apoptotic proteins via RNA-protection assay.
Main Results:
- IL-1 and ceramide significantly activated NF-kappaB levels in IEC.
- Activation of NF-kappaB correlated with decreased IkappaB-alpha and IkappaB-beta protein levels.
- IL-1 treatment led to a significant increase in the ratio of anti-apoptotic to pro-apoptotic mRNA in IEC.
Conclusions:
- NF-kappaB plays a crucial role in regulating pro-inflammatory and/or apoptotic gene expression.
- NF-kappaB represents an attractive therapeutic target for inflammatory bowel disease (IBD).
Background:
Interleukin-1 (IL-1), an inflammatory cytokine whose levels are elevated in inflamed mucosa, causes part of its effect on intestinal epithelial cells (IEC) through inducing ceramide production.
Aim:
To study the role of nuclear factor-kappaB (NF-kappaB), a pro-inflammatory and anti-apoptotic factor, in IL-1-treated IEC.
Methods:
NF-kappaB activity and levels of apoptotic proteins were assessed by electrophoretic mobility shift assay and RNA-protection assay, respectively.
Results:
IL-1 and ceramide, which have been shown to partially mediate IL-1 effects on IEC, activated NF-kappaB levels significantly. This activation was due to a decrease in IkappaB-alpha and IkappaB-beta protein levels. Moreover, the ratio of mRNA levels of anti-apoptotic to pro-apoptotic proteins was significantly increased in IL-1-treated IEC.
Conclusion:
NF-kappaB may play a key role in the regulation of the expression of pro-inflammatory and/or apoptotic genes in inflammatory bowel disease, making this protein an attractive target for therapeutic intervention.
More Related Videos
Related Concept Videos
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Renewal of Intestinal Stem Cells
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

